Save your place

Sign in to WhoBought

Please try again later.

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) institutional ownership

Latest close $14.06 Jul 24, 2026
Market cap$154M 52-week range SectorHealthcare
Funds holding · Q1 2026
79
reported CTNM position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
48 buyers · 31 sellers

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) price and institutional activity

Dates

Q1 2026

$0 bought by 48 investors
Millennium Management LLCIkarian Capital, LLC +46 more
$0 sold by 31 investors
Ra Capital Management, L.P.Commodore Capital LP +29 more
Bought Sold Totals per quarter; hover a bar for the names.

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) institutional activity · 79

Investor Type Est. change Change Δ Own Date
Ra Capital Management, L.P. · Reduced
Change −884K Date Q1 2026
Ra Capital Management, L.P. Reduced· Q1 2026 −884K Q1 2026
Commodore Capital LP · Exited
Change −816K Δ Own −100.0% Date Q1 2026
Commodore Capital LP Exited· Q1 2026 −816K −100.0% Q1 2026
Millennium Management LLC · Added
Change +705K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +705K Q1 2026
Point72 Asset Management, L.P. · Reduced
Change −674K Δ Own −88.8% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −674K −88.8% Q1 2026
Ikarian Capital, LLC · Added
Change +525K Date Q1 2026
Ikarian Capital, LLC Added· Q1 2026 +525K Q1 2026
Jones Hill Capital LP · New
Change +513K Date Q1 2026
Jones Hill Capital LP New· Q1 2026 +513K Q1 2026
Citadel Advisors LLC New· Q1 2026 +350K Q1 2026
Janus Henderson Group PLC · Added
Change +286K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +286K Q1 2026
Longaeva Partners L.P. · Added
Change +262K Date Q1 2026
Longaeva Partners L.P. Added· Q1 2026 +262K Q1 2026
Ameriprise Financial Inc · Exited
Change −210K Δ Own −100.0% Date Q1 2026
Ameriprise Financial Inc Exited· Q1 2026 −210K −100.0% Q1 2026
Perceptive Advisors LLC · Reduced
Change −209K Date Q1 2026
Perceptive Advisors LLC Reduced· Q1 2026 −209K Q1 2026
Goldman Sachs Group Inc · Added
Change +202K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +202K Q1 2026
Qube Research & Technologies Ltd · Added
Change +189K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +189K Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −157K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −157K Q1 2026
Boothbay Fund Management, LLC · Added
Change +150K Date Q1 2026
Boothbay Fund Management, LLC Added· Q1 2026 +150K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 79

Famous investor activity in Contineum Therapeutics, Inc. Class A Common Stock (CTNM)

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lorrain Daniel S. · Officer Sell −$400
Price $16.00 Qty −25 Owned 135K ΔOwn 0.0% Trade date Jul 9, 2026 Filed date Jul 10, 2026
Lorrain Daniel S. Officer Sell $16.00 −25 −$400 135K 0.0% Jul 9, 2026 Jul 10, 2026
Lorrain Daniel S. · Officer 2 operations 0
Price $1.01 Owned 33K Trade date Jul 9, 2026 Filed date Jul 10, 2026
Lorrain Daniel S. Officer 2 operations $1.01 0 33K Jul 9, 2026 Jul 10, 2026
Lorrain Daniel S. · Officer Sell −$16K
Price $16.00 Qty −1K Owned 135K ΔOwn −0.7% Trade date Jul 8, 2026 Filed date Jul 10, 2026
Lorrain Daniel S. Officer Sell $16.00 −1K −$16K 135K −0.7% Jul 8, 2026 Jul 10, 2026
Lorrain Daniel S. · Officer 2 operations 0
Price $1.01 Owned 33K Trade date Jul 8, 2026 Filed date Jul 10, 2026
Lorrain Daniel S. Officer 2 operations $1.01 0 33K Jul 8, 2026 Jul 10, 2026
Stengone Carmine N. · Director Sell −$40K
Price $16.00 Qty −2K Owned 17K ΔOwn −12.7% Trade date Jul 8, 2026 Filed date Jul 8, 2026
Stengone Carmine N. Director Sell $16.00 −2K −$40K 17K −12.7% Jul 8, 2026 Jul 8, 2026
Stengone Carmine N. · Director 2 operations 0
Price $1.01 Owned 279K Trade date Jul 8, 2026 Filed date Jul 8, 2026
Stengone Carmine N. Director 2 operations $1.01 0 279K Jul 8, 2026 Jul 8, 2026
Lorrain Daniel S. · Officer 2 operations −$132K
Price $15.67–$16.24 Qty −8K Owned 135K ΔOwn −5.8% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Lorrain Daniel S. Officer 2 operations $15.67–$16.24 −8K −$132K 135K −5.8% Jul 1, 2026 Jul 2, 2026
Lorrain Daniel S. · Officer 2 operations 0
Price $1.01 Owned 34K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Lorrain Daniel S. Officer 2 operations $1.01 0 34K Jul 1, 2026 Jul 2, 2026
Lorrain Daniel S. · Officer Sell −$462K
Price $16.04 Qty −29K Owned 139K ΔOwn −17.1% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Lorrain Daniel S. Officer Sell $16.04 −29K −$462K 139K −17.1% Jun 30, 2026 Jul 2, 2026
Lorrain Daniel S. · Officer 2 operations 0
Price $1.01 Owned 38K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Lorrain Daniel S. Officer 2 operations $1.01 0 38K Jun 30, 2026 Jul 2, 2026
Watkins Tim · Officer Sell −$174K
Price $16.02 Qty −11K Owned 9K ΔOwn −54.7% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Watkins Tim Officer Sell $16.02 −11K −$174K 9K −54.7% Jun 30, 2026 Jul 1, 2026
Watkins Tim · Officer 2 operations 0
Price $4.50 Owned 238K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Watkins Tim Officer 2 operations $4.50 0 238K Jun 30, 2026 Jul 1, 2026
Stengone Carmine N. · Director Sell −$160K
Price $16.01 Qty −10K Owned 17K ΔOwn −36.7% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Stengone Carmine N. Director Sell $16.01 −10K −$160K 17K −36.7% Jun 30, 2026 Jul 1, 2026
Stengone Carmine N. · Director 4 operations 0
Price $1.01–$1.26 Owned 118K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Stengone Carmine N. Director 4 operations $1.01–$1.26 0 118K Jun 30, 2026 Jul 1, 2026
Miralles Gines Diego · Director Grant (A) 19K
Owned 19K Trade date Jun 26, 2026 Filed date Jun 26, 2026
Miralles Gines Diego Director Grant (A) 19K 19K Jun 26, 2026 Jun 26, 2026
15 of 53
15 of 53 Sign in to continue to older insider transactions.

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Johnson & Johnson 2.0M
% of shares outstanding 10.7% Filing date Apr 10, 2024
Johnson & Johnson 2.0M 10.7% Apr 10, 2024
Suvretta Capital Management, LLC 1.7M
% of shares outstanding 9.3% Filing date Apr 15, 2024
Suvretta Capital Management, LLC 1.7M 9.3% Apr 15, 2024
Perceptive Advisors LLC 1.4M
% of shares outstanding 7.5% Filing date May 15, 2025
Perceptive Advisors LLC 1.4M 7.5% May 15, 2025
Balyasny Asset Management L.P. 2.4M
% of shares outstanding 7.4% Filing date May 15, 2026
Balyasny Asset Management L.P. 2.4M 7.4% May 15, 2026
Sectoral Asset Management Inc 951K
% of shares outstanding 5.0% Filing date Nov 14, 2024
Sectoral Asset Management Inc 951K 5.0% Nov 14, 2024
Sectoral Asset Management Inc 801K
% of shares outstanding 4.2% Filing date Feb 14, 2025
Sectoral Asset Management Inc 801K 4.2% Feb 14, 2025
Ra Capital Management, L.P. 1.3M
% of shares outstanding 4.0% Filing date May 15, 2026
Ra Capital Management, L.P. 1.3M 4.0% May 15, 2026
Millennium Management LLC 932K
% of shares outstanding 2.8% Filing date Jul 17, 2026
Millennium Management LLC 932K 2.8% Jul 17, 2026
8 of 8

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) ownership FAQ

Who owns CTNM?

79 reporting institutions disclosed CTNM position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.